Eso 40 Tablet

About Eso 40 Tablet

Eso 40 is a 40 mg tablet made by Asiatic Laboratories Ltd. that contains esomeprazole, a medicine that reduces the amount of acid the stomach produces. It is used for acid-related stomach and food-pipe problems.

There are 161 brands of Esomeprazole listed in Bangladesh. The lowest listed price is Emo 20 mg Tablet at ৳ 1 per unit.

What is Eso 40 Tablet?

Eso 40 Tablet is a proton pump inhibitor. It works by blocking the small pumps in the stomach's acid-making cells, so less acid is released into the stomach. This helps relieve heartburn and other symptoms of acid reflux, allows irritated food-pipe tissue to heal, and supports treatment to clear Helicobacter pylori infection when used with other medicines. Each tablet contains 40 mg of esomeprazole. Your doctor will decide the dose and how long you take it, based on your condition. Do not change the dose yourself.

Uses of Eso 40

Eso 40 is used to ease long-standing heartburn and other reflux symptoms, to help heal and then maintain healing of acid-damaged food-pipe tissue, and as part of a combination with other antibiotics to clear Helicobacter pylori infection in people with duodenal ulcer disease. Only a doctor can confirm whether it suits your condition.

How to use Eso 40

Swallow the tablet with water as your doctor advises. Esomeprazole is generally taken before a meal; ask your doctor or pharmacist about the exact timing for you. Do not crush or chew the tablet unless your doctor or pharmacist says it is fine. The doctor sets the dose and how long the course lasts. If you miss a dose, ask your pharmacist what to do rather than doubling up.

Side effects of Eso 40

Some people get headache, diarrhoea, nausea, wind, stomach pain, constipation or a dry mouth. These are the most commonly reported effects. Most people do not have serious problems, but tell your doctor if any effect bothers you or does not go away. Seek medical help quickly if you have a severe reaction such as swelling, trouble breathing or a bad skin rash. Ask your doctor or pharmacist about anything you notice while taking Eso 40.

Safety and precautions

Tell your doctor before taking Eso 40 if you are allergic to esomeprazole or any ingredient in the tablet. A good response to treatment does not rule out a serious stomach problem, so ongoing symptoms should be checked by a doctor. There are no adequate, well-controlled studies of esomeprazole in pregnant women; animal studies showed no harm to the unborn baby. It is not known whether esomeprazole passes into breast milk, so breastfeeding should be stopped if the doctor considers this medicine essential. Always ask your doctor first if you are pregnant, planning a pregnancy or breastfeeding.

Frequently asked questions

What does the 40 mg strength and tablet form mean?

Eso 40 comes as a tablet, a solid form you swallow with water, and each tablet contains 40 mg of esomeprazole. The doctor decides the dose and how long you take it; the strength on the pack does not mean you should take it in any particular way.

What is Eso 40 used for and what kind of medicine is it?

Eso 40 is a proton pump inhibitor, a medicine that lowers stomach acid. It is used for long-standing heartburn and reflux symptoms, for healing and maintaining healing of acid-damaged food-pipe tissue, and with other antibiotics to clear Helicobacter pylori infection in duodenal ulcer disease.

Is Eso 40 safe in pregnancy or breastfeeding?

There are no adequate, well-controlled studies in pregnant women; animal studies showed no harm to the unborn baby. It is not known whether esomeprazole passes into breast milk, so breastfeeding should be stopped if the doctor considers it essential. Ask your doctor before using it if pregnant or breastfeeding.

What should I tell my doctor before starting Eso 40?

Tell your doctor about any allergy to esomeprazole or the tablet's ingredients, any other medicines you take, and whether you are pregnant, planning a pregnancy or breastfeeding. Also mention if symptoms continue, because a good response does not rule out a serious stomach problem.

Indications

Esomeprazole is indicated:
  • To relieve from chronic heartburn symptoms and other symptoms associated with GERD
  • For the healing of erosive esophagitis
  • For maintenance of healing of erosive esophagitis
  • In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
  • ... Read more
Esomeprazole is indicated:
  • To relieve from chronic heartburn symptoms and other symptoms associated with GERD
  • For the healing of erosive esophagitis
  • For maintenance of healing of erosive esophagitis
  • In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
  • Zollinger-Ellison Syndrome
  • Acid related Dyspepsia
  • Duodenal & Gastric ulcer

Pharmacology

Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole (S-isomer of omeprazole) is the first single optical isomer of proton pump inhibitor, provides better acid control than racemic proton pump inhibitors.

Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals.

Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.

Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.

Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces.

Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.

Dosage & Administration

Healing of Erosive Esophagitis: 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive

Esophagitis: 20 mg Once Daily (Clinical studies did not extend 6 months).

Symptomatic GERD: 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.

Helicobacter Pylori eradication: Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.

Zollinger-Ellison Syndrome: The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.

Acid-related Dyspepsia: 20-40 mg once daily for 2-4 weeks according to the response.

Duodenal ulcer: 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.

Injection: The recommended adult dose is 40 mg Esomeprazole given once daily by intravenous injection (not less than 3 minutes) or intravenous infusion (10 to 30 minutes). Esomeprazole IV injection should not be administered concomitantly with any other medications through the same intravenous site. Treatment with Esomeprazole IV injection should be discontinued as soon as the patient is able to resume treatment with Esomeprazole delayed-release capsules. Safety and effectiveness in paediatric patients have not been established.

Interaction

Esomeprazole is extensively metabolized in the liver by CYP2C19 and CYP3A4. In vitro and in vivo studies have shown that Esomeprazole is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that Esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin.

Esomeprazole may potentially interfere with CYP2C19, the major Esomeprazole metabolizing enzyme. Co-administration of Esomeprazole 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Esomeprazole inhibits gastric acid secretion. Therefore, Esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin).

Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Esomeprazole.

Combination Therapy with Clarithromycin: Co-administration of esomeprazole, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of esomeprazole and 14-hydroxyclarithromycin.

Contraindications

Esomeprazole is contraindicated in-patient with known hypersensitivity to any of the formulation.

Side Effects

The most frequently occurring adverse events reported with Esomeprazole include headache, diarrhoea, nausea, flatulence, abdominal pain, constipation and dry mouth. There are no difference in types of related adverse events seen during maintenance treatment upto 12 months compared to short term treatment.

Pregnancy & Lactation

There are no adequate and well-controlled studies in pregnant women. Animal studies have revealed no teratogenic effects. The excretion of esomeprazole in milk has not been studied. Breast-feeding should be therefore be discontinued if the use of esomeprazole is considered essential.

Precautions & Warnings

General: Symptomatic response to therapy with esomeprazole does not preclude the presence of gastric malignancy.

Information for patients: Esomeprazole capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Esomeprazole capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking esomeprazole.

Overdose Effects

A single oral dose of Esomeprazole at 510 mg/kg (about 103 times the human dose on a body surface area basis), has been lethal to rats. The major signs of acute toxicity are reduced motor activity, changes in respiratory frequency, tremor, ataxia, and intermittent clonic convulsions. There have been no reports of overdose with Esomeprazole. No specific antidote for Esomeprazole is known. Since Esomeprazole is extensively protein bound, it is not expected to be removed by dialysis. In the event of overdosage, treatment should be symptomatic and supportive. As with the management of any overdose, the possibility of multiple drug ingestion should be considered.

Storage Conditions

Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.

Alternative brands of Esomeprazole

Other brands with the same generic name, cheapest first.

Emo Tablet

20 mg

Esomeprazole

Pharmadesh Laboratories Ltd.

৳ 1 per unit

Esru Tablet

20 mg

Esomeprazole

Doctor's Chemicals Works Ltd.

৳ 4.00 per unit

Eso Tablet

20 mg

Esomeprazole

Asiatic Laboratories Ltd.

৳ 5.00 per unit

See all 161 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.